Document Type
Article
Original Publication Date
2022
Journal/Book/Conference Title
HeartRhythm Case Reports
Volume
8
Issue
3
First Page
217
Last Page
221
DOI of Original Publication
10.1016/j.hrcr.2021.12.015
Date of Submission
November 2023
Abstract
Catheter ablation is recognized as a central therapeutic option in treating patients with drug-refractory, scar-related monomorphic ventricular tachycardia (VT). Catheter ablation also has a role in selected cases of polymorphic VT (PMVT) and/or ventricular fibrillation (VF). Rarely, premature ventricular contractions (PVCs) originating from the Purkinje network can induce PMVT/VF. Although not completely elucidated, the electrophysiologic mechanisms behind this lethal arrhythmia have generally been thought to be related to abnormal automaticity and triggered activity. Ablation of the triggering PVCs can prevent VF recurrence and is potentially lifesaving
Rights
© 2021 Heart Rhythm Society. This article is available under the Creative Commons CC-BY-NC-ND license and permits non-commercial use of the work as published, without adaptation or alteration provided the work is fully attributed
Is Part Of
VCU Internal Medicine Publications
Supplemental Figure 1
Comments
Originally published at https://doi.org/10.1016/j.hrcr.2021.12.015